HIV infection and coronary heart disease: mechanisms and management

Nat Rev Cardiol. 2019 Dec;16(12):745-759. doi: 10.1038/s41569-019-0219-9. Epub 2019 Jun 10.

Abstract

Antiretroviral therapy has largely transformed HIV infection into a chronic disease condition. As such, physicians and other providers caring for individuals living with HIV infection need to be aware of the potential cardiovascular complications of HIV infection and the nuances of how HIV infection increases the risk of cardiovascular diseases, including acute myocardial infarction, stroke, peripheral artery disease, heart failure and sudden cardiac death, as well as how to select available therapies to reduce this risk. In this Review, we discuss the epidemiology and clinical features of cardiovascular disease, with a focus on coronary heart disease, in the setting of HIV infection, which includes a substantially increased risk of myocardial infarction even when the HIV infection is well controlled. We also discuss the mechanisms underlying HIV-associated atherosclerotic cardiovascular disease, such as the high rates of traditional cardiovascular risk factors in patients with HIV infection and HIV-related factors, including the use of antiretroviral therapy and chronic inflammation in the setting of effectively treated HIV infection. Finally, we highlight available therapeutic strategies, as well as approaches under investigation, to reduce the risk of cardiovascular disease and lower inflammation in patients with HIV infection.

Publication types

  • Review

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Atherosclerosis / etiology
  • Coronary Disease / complications*
  • Coronary Disease / epidemiology
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology
  • HIV Infections / physiopathology
  • Humans
  • Risk Factors

Substances

  • Anti-HIV Agents